Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_753eb3c1ea6051941ae68e70415c8071 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-868 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
filingDate |
1999-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca02c608872004428b6784d8485d928c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc58425a5286567451fc7314c949038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4dbb44d9386bb12faadce842c1f3527 |
publicationDate |
2003-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-510927-A |
titleOfInvention |
Immunodiagnostics using particle delivery methods |
abstract |
A method for assessing an allergic condition comprises: a) accelerating particles comprising an allergen into a target skin site in the individual and b) assessing the target site to determine the presence or absence of a localized skin immune reaction wherein the presence of a skin reaction is indicative of an allergic condition in the individual. A method for assessing a delayed type hypersensitivity (DTH) reaction in an individual and the use of an immunogenic moiety or an allergen in the manufacture of particulate compositions for assessing an immune response or an allergic condition is described. Preferably the immunogenic moiety is an allergen or an antigen selected from a pathogenic agent, a cancer antigen or a red blood cell Rh antigen |
priorityDate |
1998-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |